Polynovo Stock

Polynovo P/E 2024

Polynovo P/E

306.19

Ticker

PNV.AX

ISIN

AU000000PNV0

WKN

A12F4T

As of Dec 18, 2024, Polynovo's P/E ratio was 306.19, a -250.36% change from the -203.64 P/E ratio recorded in the previous year.

The Polynovo P/E history

Polynovo Aktienanalyse

What does Polynovo do?

Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Polynovo's P/E Ratio

The Price to Earnings (P/E) Ratio of Polynovo is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Polynovo's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Polynovo is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Polynovo’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Polynovo stock

What is the price-to-earnings ratio of Polynovo?

The price-earnings ratio of Polynovo is currently 306.19.

How has the price-earnings ratio of Polynovo changed compared to last year?

The price-to-earnings ratio of Polynovo has increased by -250.36% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Polynovo high compared to other companies?

Yes, the price-to-earnings ratio of Polynovo is high compared to other companies.

How does an increase in the price-earnings ratio of Polynovo affect the company?

An increase in the price-earnings ratio of Polynovo would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Polynovo affect the company?

A decrease in the price-earnings ratio of Polynovo would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Polynovo?

Some factors that influence the price-earnings ratio of Polynovo are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Polynovo pay?

Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.

What is the dividend yield of Polynovo?

The current dividend yield of Polynovo is .

When does Polynovo pay dividends?

Polynovo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Polynovo?

Polynovo paid dividends every year for the past 0 years.

What is the dividend of Polynovo?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Polynovo located?

Polynovo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Polynovo from 12/18/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Polynovo pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Polynovo in the year 2023?

In the year 2023, Polynovo distributed 0 AUD as dividends.

In which currency does Polynovo pay out the dividend?

The dividends of Polynovo are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Polynovo

Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.